 value class IC drugs acute conversion paroxysmal atrial fibrillation flutter rhythm single-blind randomized study efficacy safety intravenous propafenone mg/kg body min versus flecainide mg/kg min patients atrial fibrillation flutter Treatment successful sinus rhythm Conversion patients atrial fibrillation propafenone atrial fibrillation flecainide atrial fibrillation present equal conversion rhythm patients propafenone group flecainide group Atrial flutter patients propafenone flecainide NS Mean time conversion min propafenone group min flecainide group NS QRS lengthening ms patients flecainide propafenone plasma levels arrhythmia rhythm Transient adverse effects frequent flecainide group propafenone group conclusion dose mg/kg min flecainide effective propafenone conversion paroxysmal atrial fibrillation rhythm propafenone plasma levels adverse effects dose infusion rate propafenone group sufficient optimal effect drug effective patients atrial flutter